Stratos Wealth Partners’s Mural Oncology MURA Stock Holding History
Bought
Maintained
Sold
Other funds holding MURA
SCM
PM
ACA
O
NM
LP
DC
Stratos Wealth Partners's MURA Position: Q2 2025 in Review
Stratos Wealth Partners sold out of Mural Oncology (MURA) in Q2 2025, closing a stake of 18,300 shares — an estimated $23.1K sold.
Stratos Wealth Partners first reported a position in MURA in Q1 2025 and held it in 1 quarter. The position peaked at $23.1K in Q1 2025. 66 funds tracked by Wall St. Rank hold MURA as of Q2 2025.
- Stratos Wealth Partners reported no remaining Mural Oncology position as of Q2 2025 after selling out during the quarter.
- Stratos Wealth Partners sold 18,300 Mural Oncology shares in Q2 2025, an estimated $23.1K.
- Stratos Wealth Partners first reported a position in Mural Oncology in Q1 2025 and held it in 1 quarter.
- Stratos Wealth Partners's Mural Oncology position peaked at $23.1K in Q1 2025.
- 66 funds tracked by Wall St. Rank held Mural Oncology as of Q2 2025.
Based on Stratos Wealth Partners's 13F filing for Q2 2025, filed 29 Jul 2025.